Mirae Asset Global Etfs Holdings Ltd. Halozyme Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 76,580 shares of HALO stock, worth $4.67 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
76,580Holding current value
$4.67 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding HALO
# of Institutions
522Shares Held
123MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.07 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$786 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$355 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$246 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$227 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.49B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...